“I am so honored to have the opportunity to share my knowledge and expertise with my esteemed colleagues as we explore this critical area of study, which is increasingly gaining the momentum and recognition it deserves.” -Dr. Whitney Bowe
SAN FRANCISCO (PRWEB) October 19, 2018
uBiome, the leader in microbial genomics, announces the addition of Dr. Whitney Bowe, MD, Medical Director of Integrative Dermatology, Aesthetics & Wellness at the New York based Advanced Dermatology, P.C. practice to its Medical Advisory Board. Joining the board of leading scientists and doctors from around the world, Dr. Bowe will bring to uBiome extensive knowledge on the skin microbiome, including the link between nutrition and skincare. The appointment will help uBiome continue its advancement in human microbiome research.
“The clinical implications of the skin microbiome are very important, and Dr. Bowe is helping to bring the skin microbiome into the mainstream,” Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. “We are delighted to have her as part of uBiome’s Medical Advisory Board.”
Dr. Bowe has quickly become one of the most sought-after dermatologists around the country. Her recently published book, "The Beauty of Dirty Skin," highlights the importance of the microbiome to maintaining healthy skin. Dr. Bowe also serves as the Clinical Assistant Professor of Dermatology at the Icahn School of Medicine at Mount Sinai Medical Center where she trains physicians and surgeons in the latest groundbreaking cosmetic surgery techniques. Dr. Bowe has shared her expertise on programs including “Good Morning America,” “The Rachael Ray Show,” “The Doctors,” and “Dr. Oz,” and publications such as The Wall Street Journal, The New York Times, Allure, and Instyle. Honors include being named Top Doctor 2018 by NY Top Docs, named on The New York Times’ Top Doctors list (2017) and Super Doctors’ New York Rising Stars list (2013, 2014), among others. She has also written more than 40 peer-reviewed articles and book chapters.
About joining uBiome's Medical Advisory Board, Dr. Bowe said, “I am so honored to have the opportunity to share my knowledge and expertise with my esteemed colleagues as we explore this critical area of study, which is increasingly gaining the momentum and recognition it deserves.”
In addition to Dr. Bowe, the uBiome Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Liz Lipski (Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company’s Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children’s Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets.
uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.
uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.
Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.